Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies | Zendy

Shuiqing Wu | Zendy; Xiaokun Zhao | Zendy; Yinhuai Wang | Zendy; Zhaohui Zhong | Zendy; Lei Zhang | Zendy; Jian Cao | Zendy; Kai Ai | Zendy; Ran Xu | Zendy

Open Access

Pretreatment Neutrophil-Lymphocyte Ratio as a Predictor in Bladder Cancer and Metastatic or Unresectable Urothelial Carcinoma Patients: a Pooled Analysis of Comparative Studies

Author(s) -

Shuiqing Wu,

Xiaokun Zhao,

Yinhuai Wang,

Zhaohui Zhong,

Lei Zhang,

Jian Cao,

Kai Ai,

Ran Xu

Publication year - 2018

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000489152

Subject(s) - hazard ratio , medicine , bladder cancer , lymphovascular invasion , neutrophil to lymphocyte ratio , confidence interval , odds ratio , oncology , cancer , gastroenterology , pathological , stage (stratigraphy) , urology , lymphocyte , metastasis , biology , paleontology

Emerging studies have shown that the neutrophil-lymphocyte ratio (NLR) is a potential predictor in various tumors. Our study was conducted to assess the prognostic value of the pretreatment NLR in bladder cancer and metastatic or unresectable urothelial carcinoma (mUC or uUC) patients up to July 2017. The correlation between the pretreatment NLR and pathological characteristics was also evaluated in bladder cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research